Childress Michael O, Avery Anne, Behling-Kelly Erica, Bennett Peter, Brockley Laura, Dickinson Ryan, Hughes Kelly, Kisseberth William C, Marconato Laura, Martini Valeria, McCleary-Wheeler Angela, Minoli Lucia, Rowland Peter, Sills Shane, Aresu Luca
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.
Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
Vet Comp Oncol. 2025 Sep;23(3):331-345. doi: 10.1111/vco.13064. Epub 2025 May 19.
One of the primary objectives of the Oncology Pathology Working Group (OPWG) is for oncologists and pathologists to collaboratively generate consensus documents to standardise aspects of and provide guidelines for oncologic pathology in veterinary species. Consensus is established through critical review of the peer-reviewed literature relevant to a subgroup's particular focus. In this article, the authors provide a critical review of the current literature regarding methods for the diagnosis and classification of primary nodal lymphomas of dogs, including histopathology, cytopathology, immunophenotyping and assessment of molecular clonality. Knowledge gaps in the current literature and recommendations for future study are also reported. Major conclusions of this consensus include: (1) Histopathology with immunohistochemistry is required for complete diagnosis and classification of nodal lymphomas; (2) Immunohistochemistry and flow cytometry are the most reliable methods of immunophenotyping lymphomas, though neither is clearly superior to the other; (3) Molecular clonality testing should not be used in favour of immunophenotyping assays for classifying lymphomas; and (4) The use of emerging molecular tests for diagnosing lymphomas in the absence of histopathologic, cytopathologic, or immunophenotypic disease characterisation should be restricted to investigational settings until their diagnostic validity and the clinical benefit they confer to patients are more thoroughly characterised. This document represents the opinions of the OPWG and the authors; it does not constitute a formal endorsement by the American College of Veterinary Pathologists or the Veterinary Cancer Society.
肿瘤病理学工作组(OPWG)的主要目标之一是让肿瘤学家和病理学家共同制定共识文件,以规范兽医物种肿瘤病理学的各个方面并提供指导方针。通过对与某个亚组特定重点相关的同行评审文献进行严格审查来达成共识。在本文中,作者对当前有关犬原发性淋巴结淋巴瘤诊断和分类方法的文献进行了严格审查,包括组织病理学、细胞病理学、免疫表型分析和分子克隆性评估。还报告了当前文献中的知识空白以及对未来研究的建议。该共识的主要结论包括:(1)淋巴结淋巴瘤的完整诊断和分类需要组织病理学结合免疫组织化学;(2)免疫组织化学和流式细胞术是淋巴瘤免疫表型分析最可靠的方法,尽管两者都没有明显优于对方;(3)分子克隆性检测不应优先于免疫表型分析用于淋巴瘤分类;(4)在没有组织病理学、细胞病理学或免疫表型疾病特征描述的情况下,使用新兴分子检测诊断淋巴瘤应仅限于研究环境,直到其诊断有效性及其给患者带来的临床益处得到更全面的描述。本文件代表OPWG和作者的意见;它并不构成美国兽医病理学家学院或兽医癌症协会的正式认可。
Health Technol Assess. 2001
Cochrane Database Syst Rev. 2024-8-27
Vet Pathol. 2023-5
J Vet Diagn Invest. 2023-1
Vet Pathol. 2022-9
J Vet Intern Med. 2022-1